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With the aim of developing a sensitizer for photodynamic therapy, a previously reported luminescent 
dinuclear complex that functions as a DNA probe in live cells was modified to produce a new iso-
structural derivative containing RuII(TAP)2 fragments (TAP = 1,4,5,8- tetraazaphenanthrene). The 
structure of the new complex has been confirmed by a variety of techniques including single crystal X-ray 
analysis. Unlike its parent, the new complex displays RuL-based 3MLCT emission in both MeCN and 
water. Results from electrochemical studies and emission quenching experiments involving guanosine 
monophosphate are consistent with an excited state located on a TAP moiety. This hypothesis is further 
supported by detailed DFT calculations, which take into account solvent effects on excited state 
dynamics. Cell-free steady-state and time-resolved optical studies on the interaction of the new complex 
with duplex and quadruplex DNA show that the complex binds with high affinity to both structures and 
indicate that its photoexcited state is also quenched by DNA, a process that is accompanied by the 
generation of the guanine radical cation sites as photo-oxidization products. Like the parent complex, this 
new compound is taken up by live cells where it primarily localizes within the nucleus and displays low 
cytotoxicity in the absence of light. However, in complete contrast to [{RuII(phen)2}2(tpphz)]4+, the new 
complex is therapeutically activated by light to become highly phototoxic toward  malignant human 
melanoma cell line showing that it is a promising lead for the treatment of this recalcitrant cancer.
Introduction
A promising and emerging therapeutic regime for the treatment 
of cancer is photo-dynamic therapy (PDT).1,2 In this approach a 
photo-excitable sensitizer molecule is used to generate highly 
reactive species, most commonly singlet oxygen, 1O2, in situ. 
Whilst a number of PDT sensitizers have reached clinical trials, 
there are still very few successful commercial examples 
available; those that are currently employed frequently display 
poor water solubility and do not target cancer cells with high 
specificity, leading to generalized photosensitivity and off-target 
toxic side effects.3 Moreover, these agents are often challenging 
to synthesize and so can be costly. Furthermore, whilst the 
generation of 1O2 is essentially a photocatalytic process, one of 
the drawbacks of this approach is that many tumours are hypoxic, 
which can restrict the efficacy of PDT in these circumstances.
One alternative to conventional PDT involves the use of water-
soluble polypyridyl d6-metal complexes as sensitizers as, on  
photo-excitation with visible light, these complexes often possess 
long-lived triplet states.  Because their synthesis from specific 
metal ions and ligands is essentially modular, the photophysical 
and biophysical properties of these complexes are easily tuned.4-8 
and RuII complexes have attracted particular attention as 
sensitizers. 9-18   
For similar reasons, this class of compounds has also been 
investigated as probes for optical microscopy. A case in point is 
the probe described in previous reports by the Thomas group. We 
have identified a dinuclear RuII complex, 
[{(phen)2Ru}2(tpphz)]4+, 14+,19,20 (phen = 1,10 phenanthroline, 
tpphz = tetrapyridophenazine), Scheme 1, whose biophysical 
properties are related to the ubiquitous [Ru(bpy)2(dppz)]2+ “light-
switch” complex, (bpy = 2,2’-bipyridyl, dppz = 
dipyridophenazine).21,22 Like the parent compound, 14+ is 
virtually non-emissive in aqueous solution but - on high-affinity 
binding to DNA – it displays the familiar bright, 3MLCT-based, 
luminescence. Strikingly, the emission of 14+ is dependent on 
DNA structure:  whereas binding to canonical duplex DNA 
induces NIR emission centred at ~680 nm, binding to G-rich, 
quadruplex folded, human telomere sequence - (3’-TTAGGG-
5’)n - leads to emission at 650 nm and a greater enhancement of 
emission (x150 vs. x60).19,23 Detailed subsequent studies, 
including co-localization with nucleic acid stains and TEM 
imaging, confirmed that 14+ is taken up by live cells, where it 
localizes within the nucleus imaging heterochromatin duplex and 
quadruplex structures.24
This observation is particularly significant, as quadruplex 
structures have been hypothesized to have roles in a range of 
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biological processes, including modulation of gene expression, 
epigenetics, nucleating of DNA replication, and genetic 
disease.25-30 Consequently, this has led to a plethora of research 
into these non-canonical structures, including work on telomeres. 
Single stranded telomere sequences are found at the end of 
chromosomes and, as outlined above, are known to form 
quadruplexes. Telomeres are associated with defining the 
Hayflick limits for cell division:  each cell division results in 
shortening of the telomere sequence, until a critical length is 
reached and senescence is triggered. Given these facts, it is 
perhaps not surprising that telomere length maintenance, leading 
to cell immortalization, is an almost ubiquitous phenomenon in 
cancer cells.31,32 For this reason, selective methods to facilitate 
the attrition of telomere length in cancer cells, which often 
involve stabilization of quadruplex structures, have been 
sought.32
As 14+ binds to both quadruplex and duplex structures within 
live cells, a phototoxic analogue would function as a sensitizer 
for PDT that could additionally enhance telomere attrition rates. 
To carry out this transformation we changed the ancillary ligands 
attached to the central RuII(tpphz)RuII moiety.
Extensive studies have demonstrated that the substitution of 
conventional bpy or phen ancillary ligands with the electron 
deficient ligand tetraazaphenanthrene, TAP, produces a complex 
with strikingly different photo-excited state properties.33-37 For 
example, unlike the parent light-switch complex, 
[Ru(TAP)2(dppz)]2+ is luminescent in water but is quenched by 
binding to DNA. This is due to photo-excitation into a 
RuIITAP 3MLCT excited state which photo-oxidizes guanine 
sites when intercalated into duplex DNA. In cell free studies, a 
related dinuclear complex was shown to be a more efficient at 
photo-damaging oligonucleotides containing G than 
[Ru(TAP)2(dppz)]2+ and was particularly effective at creating 
photo-adducts when bound to quadruplex folded DNA.38 
However, cell studies on such systems are much less developed. 
Whilst it is known that, even after 24 hours exposure, 
[Ru(TAP)2(dppz)]2+ solely localizes in the cytoplasm of HeLa 
cells, 39 the Keyes group  has demonstrated that covalent 
attachment of a suitable signal peptide to a [Ru(TAP)2(bpy)]2+ 
unit leads to a construct capable of targeting cell nuclei. Although 
this hybrid system possesses considerable phototoxicity, it is 
produced on a small scale, using only 10mg of metal complex 
starting material.40. Recently, the Elias group have reported 
preliminary studies on mononuclear complexes containing the 
RuII(TAP)2 moiety coordinated to a quadruplex targeting ligand. 
Whilst this complex is phototoxic, so is its RuII(phen)2 analogue, 
suggesting that the observed phototoxicity of both complexes 
may be due to classic singlet oxygen sensitization.41
This report concerns an essentially iso-structural derivative of 
14+ containing RuII(TAP)2 fragments. In this study we describe 
the synthesis, characterization, and crystal structure of this new 
complex [{Ru(TAP2)}2(tpphz)]4+, 24+, which can be isolated in 
good yields. 
Experimental and computational studies reveal that 24+ displays a 
RuTAP MLCT excited state and cell free studies confirm that 
the complex binds to both duplex and quadruplex DNA. 
Photophysical studies confirm that the complex is capable of 
photo-oxidizing guanosine monophosphate, GMP and guanine 
sites in both duplex and quadruplex DNA.  We also find the 
complex is spontaneously taken up by live melanoma cells, where 
it localizes in the nucleus and displays potent photo-toxicity, 
indicating that it is a readily accessible, highly promising, 
photosensitizer for the treatment of a highly malignant 
recalcitrant cancer.
Scheme 1. Structures of 14+ and 24+. 
Results and Discussion
We initially set out to synthesize the TAP ligand following 
established literature procedures.34,42 The diaminoquinoxaline 
precursor was readily obtained using the route described by 
Elmes, et al.42 However, in our hands, existing literature 
procedures for the final synthesis of TAP from this intermediate 
proved to be unreliable and low yielding. We found that by using 
isopropanol as the reaction solvent, along with 1.5 equivalents of 
glyoxal, the production of intractable side-products could be 
eliminated, yielding 80% of pure TAP after work-up.
Complex 24+ was synthesized through an analogous route to 
that used for 14+ (see SI for a reaction scheme and experimental 
details).19 However, in coupling the two {Ru(TAP)2} cores to the 
tpphz bridge, we found it was necessary to use more forcing 
reaction conditions that for the related phen or bpy complexes. 
This is most likely due to the more strongly electron-deficient 
nature of the TAP ligand reducing the donor strength of the 
chelating N lone pairs. A microwave-assisted synthesis adapted 
from a previous report,39  combined with purification through 
alumina column chromatography and then ion-exchange 
chromatography on Sephadex-LH25 yielded analytically pure 24+ 
as a chloride salt in 55% yield. For spectroscopic studies, the 
hexafluorophosphate was also isolated by anion metathesis.
Fig. 1 Thermal ellipsoid diagram showing the Δ,Δ cation of the [2]Cl4 
structure. Hydrogen atoms have been omitted for clarity. 
Crystals suitable for x-ray crystallography were grown by slow 
vapour diffusion of acetone into a saturated solution of 24+ in 
methanol. Although the quality of the data  (R = 9.27) prevents a 
full analysis of bond length and angles, it does confirm 
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connectivities. Interestingly, like the corresponding structure of 
[{(bpy)2Ru}2(tpphz)]4+,43 the resultant unit cell contains two 
stereoisomers of 24+ - the  and  forms - with no evidence 
of the meso  form apparent in the crystal data. One of these 
cations (the Δ,Δ cation) is shown in Figure 1.
Two of the chloride counter ions are disordered, and a number 
of highly disordered water molecules are present within a solvent 
cavity, which were accounted for in the refinement using a 
solvent mask. 
Table 1. Photophysical data for complex 24+
Complex Absorption Emission
max (nm) 
(L mol-1 cm-1)
max (nm) Quantum Yield Lifetime (ns)
[2].Cl4 423
452
41,800
33,300
628 0.05 (Water)
0.04 (Phosphate)
0.07 (TRIS)
650 ± 24
575 ± 37
 723± 23
[2].(PF6)4b 423
452
41,800
34,800
613 0.04 550 ± 30
a Measured in H2O. b Measured in MeCN
The distorted octahedral geometry around each ruthenium (II) 
core is essentially identical, with a N1-Ru1-N6 angle of 171.8° 
and the average bond length for the 4 TAP ligands of 2.052 A. 
The tpphz bridging ligand displays a marked twist –the angle 
between the planes of the two “bpy” moieties of the tpphz gives a 
twist of 10.4°. As might be expected, the observed bond angles 
and lengths are comparable to those of [{(bpy)2Ru}2(tpphz)]4+.
The UV/Vis absorption spectra of [2](PF6)4 and [2]Cl4 were 
measured in acetonitrile and water respectively. Apart from the 
expected high-energy intraligand bands, the complex possesses 
an absorption between 400–500 nm, an energy that is typical for a 
RuL 1MLCT transition, see Fig. 2 and Table 1, but it is 
substantially more intense than the equivalent transition for 14+. 
The energy of the 1MLCT does not significantly change in 
acetonitrile compared to aqueous environments, although changes 
in relative intensities within the band suggests that it is composed 
of at least two intense, overlapping transitions.
Fig. 2  UV/Vis absorption spectra (left) and emission spectra (right) of 
[2]Cl4 and [2](PF6)4 in water, acetonitrile and phosphate buffer (10 mM 
KH2PO4, 200 mM KCl, pH 7.2, 20 mM EDTA). 
The emission spectra of [2](PF6)4 and [2]Cl4 were also 
measured in acetonitrile  and water respectively (Figure 2, Table 
1). The complex displays bright emission between 600-750 nm in 
both solvents, which is in direct contrast to the properties of 14+,19 
which is quenched in aqueous media.44 The emission wavelength 
and lifetimes in acetonitrile were very similar to those in aqueous 
conditions, with only a small blue shift in max alongside an 
approximately 20% decrease in emission lifetime and quantum 
yield. These observations reveal a significant difference in the 
lowest excited state of 24+ compared to 14+, suggesting that – as 
expected - the emissive state of 24+ is a TAP-based 3MLCT rather 
than the tpphz-based 3MLCT of 14+. As expected from these 
observations, emission quantum yield are similar, regardless of 
solvent environment.
Fig. 3 Cyclic voltammogram for 1 mM [2](PF6)4: in dry DMF with 0.1M 
N(n-Bu)4PF6 supporting electrolyte. Red and blue lines show isolated sets 
of reductions.
The electrochemical properties of 24+ were investigated in dry 
acetonitrile. The complex displays a single oxidation at 
approximately 1.8 V vs. Ag/AgCl, which appears to be 
reversible, although it occurs at the edge of the solvent window. 
This potential is almost identical to that reported for the 
mononuclear [Ru(TAP)2dppz]2+ complex34 (+1.82 V vs. 
Ag/AgCl), and is therefore  assigned to the expected reversible 
RuII/III  oxidation.  The reduction of the complex in acetonitrile 
results in a large stripping peak on the return sweep. This 
behaviour has been previously observed for dinuclear complexes 
with a tpphz bridge44 and suggests the reduced form of the 
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complex displays low solubility in MeCN. Therefore, the 
reduction potentials were also measured in dry DMF (Figure 3).
Several reduction waves are observed in these conditions. Two 
distinct reversible reductions occur at -0.70 V and -0.86 V, with 
further poorly resolved couples occurring between -1.4 to -1.8 V. 
Given that the emissive state of [2]Cl4 is not quenched in water, 
which implies a TAP-based lowest excited state, the reduction at 
-0.70 V is assigned to the first reduction of the TAP ligand, which 
is similarly observed in the mononuclear Ru-TAP analogues.33,45 
A second reduction process at -0.86 V is also consistent with the 
reduction of a TAP ligand coordinated to the second Ru centre. 
Through comparison to related complexes, the overlapping redox 
processes between -1.4 V to -1.8 V are assigned to a combination 
of reductions of the tpphz bridging unit, and further reductions of 
TAP ligands.
Fig. 4 Lowest triplet structures for 14+ in MeCN [panel (a)], 24+ in MeCN 
[panel (b)], and 24+ in water [panel (c)]. Blue indicates  spin, whereas 
red indicates  spin.
To elucidate our results further a series of density functional 
calculations using Gaussian0946 was performed employing 
methods and procedures outlined in the supporting information. 
Calculations were performed on 14+ in acetonitrile and on 24+ in 
both acetonitrile and water. In these calculations, we included 
solvent using a continuum model for MeCN. However, from 
previous work,47 it is clear that some explicit water molecules are 
needed to describe the electronic structure of these compounds in 
water correctly, especially since it is known that hydrogen 
bonding plays an important role in the excited states dynamics of 
complexes such as 24+.
The final optimized structures for the triplet states are given in 
Figure 4, with the spin density super-imposed on the final 
structure. In these calculations, the singlet (ground-state) 
structures are indistinguishable from the triplet structures and can 
be found in the SI.
The spin densities and geometries in Figure 4 show very 
clearly that, although replacing phen with TAP has little 
structural effect, the substitution leads to significant electronic 
changes. In particular, the spin density clearly shows that for 24+ 
(irrespective of the solvent) the triplet excited state has its density 
on one of the TAP ligands, whereas for 14+ it is situated on the 
tpphz, confirming our experimental observations (vide supra). 
Close inspection of the LUMO and LUMO+1 orbitals shows that 
these are part of a (near-) degenerate pair, so that small geometric 
distortions may alter the specific TAP on which the excited state 
localizes.
In the calculations associated with Figure 4(c), water 
molecules were placed in hydrogen-bonding positions around 24+. 
These interactions will be associated with many orientations of 
very similar energies. However, an exhaustive search on this 
issue is outside the scope of this paper and will most likely lead 
to very similar results. Nevertheless, it is interesting to note that 
two water molecules bonding to the central tpphz moiety, which 
were originally placed in a hydrogen-bonding position, rotated 
and are in a hydrogen-accepting orientation in the final structure. 
This observation suggests that the nitrogen atoms of the tpphz 
bridge are not accessible to hydrogen-bonding, indicating that 
some of the deactivation pathways available to similar complexes 
incorporating the RuII(dppz) unit cannot be accessed by 24+.
Using the singlet geometries, UV-VIS spectra were simulated 
through TD-DFT calculations, which show qualitative agreement 
with the experimental absorption spectrum (see SI Figure S-9). 
However, our calculations also show that there are many 
transitions underlying absorption bands in the visible region. To 
investigate whether the nature of the transitions is affected by 
changing the solvent from MeCN to water, a wave function 
analysis48-50 was performed on the highest fifty states in the TD-
DFT calculation. The strongest five transitions from this analysis 
are also represented graphically in the SI (see Figure S-10).
The wave function analysis indicated that transitions in both 
solvents occur at similar energies, resulting in what appear to be 
the near-identical experimental UV-VIS spectra shown in Figure 
2. However, it is also clear that the nature of each of these 
transitions is very different. 
Again, the analysis yields results that are consistent with the 
experimental data. For example, in MeCN and water, transitions 
with similar energy - at 425.8 and 421.0 nm, respectively - are 
predicted. Yet, whilst this transition in MeCN is assigned to a 
MLCT from both Ru atoms onto the tpphz bridge, in water the 
transition is predicted to be a MLCT from the Ru atoms onto the 
TAP units. Interestingly, some of the transitions are completely 
different in their nature. For example, transitions at 389.1 nm and 
386.5 nm in MeCN are again MLCT transitions onto tpphz, but in 
water, where these transitions occur at 385.0 nm and 381.0 nm, 
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respectively, they are inter-ligand transitions from tpphz onto 
TAP for the latter transition and a mix of inter-ligand transitions 
and an MLCT transition for the former transition.
Fig. 5 Difference density maps for 22+ in acetonitrile [panels (a) and (b)] 
and water [panels (c) and (d). Panel (a): Differential density for reduction 
from 24+ to 23+ in MeCN. Panel (b): Differential density for reduction 
from 23+ to 22+ in MeCN. Panel (c): Differential density for reduction 
from 24+ to 23+ in water. Panel (d): Differential density for reduction from 
23+ to 22+ in water. Blue indicates increase of electron density, whereas 
red indicates loss of electron density. (See SI for the methodology used.).
The calculated triplet geometries and corresponding singlet 
states were also used to predict the emission wavelength 
assuming no geometrical relaxation. In MeCN, the emission 
maximum of 24+ was calculated to be at 647 nm and in water the 
corresponding wavelength was predicted to be 677 nm. The 
corresponding emission wavelengths for the 0-0 transitions 
(which includes geometric relaxation) were at 607 and 637 nm, 
respectively. In both cases, there is a correlation with both the 
ordering and approximate energies of experimentally measured 
spectra as shown in figure 2.
Finally, the behaviour upon reduction of these complexes was 
investigated computationally. The differences in electron density 
for the first and second reduction of 24+ in both MeCN and water 
were calculated and are shown in Figure 5.
Concentrating on the panels (c) and (d) first, the calculations 
are in agreement with the experimental data. They clearly 
indicate that both reductions are mainly centred on the TAP 
ligands. It is also clear that the water molecules do not play a 
direct role in the reduction, in that there is no density difference 
associated with them. However, water molecules do respond to 
the reduction by adapting their orientation with respect to 24+ as is 
clear from panel (d), where the water molecules bonded to the 
tpphz ligand in 23+ are polarized towards the reduced TAP ligand.
The situation in MeCN as shown in panels (a) and (b) of 
Figure 5 is somewhat different. Here, the first reduction is of the 
tpphz ligand, whereas the TAP ligands are reduced in the second 
reduction. This is in line with the virtual orbitals of 24+ in MeCN, 
but is different from what happens upon photo-excitation, where 
the triplet state is clearly located on the TAP ligand. Clearly, 
these virtual orbitals are close enough to facilitate this re-
arrangement upon reorganization of electron density. It should be 
pointed out that this result is slightly different to the observed 
electrochemistry for [2](PF6)4; however, the experimental data 
were collected in DMF and it the calculations indicate that the 
electronic structure of this system is solvent dependent. 
Given the interesting redox properties of 24+ revealed by the 
experimental data and computational studies, the photo-oxidizing 
properties of the complex were investigated.
Fig. 6 Stern-Vollmer plot for the emission of [2]Cl4 quenched by the 
addition of guanosine monophosphate, showing change in lifetime and 
emission intensity.
It has previously been demonstrated that [Ru(TAP)2(dppz)]2+ and 
related complexes photo-oxidize DNA through electron transfer 
from guanine sites to the photo-excited complex, quenching its 
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emissive state. 33,34,36 35,51 Therefore the effect of increasing 
concentrations of nucleotide monophosphates on the emission 
spectrum of 24+ was investigated and as expected these revealed 
that only addition of GMP led to emission quenching  (Figure 6).
The difference between I0/I and τ0/τ as a function of quencher 
concentration indicate that emission changes are caused by both 
dynamic and static quenching processes. Such effects often occur 
through stacking interactions between nucleotides and 
luminophores52,53, therefore this possibility was investigated 
using 1H-NMR.
Although distinct changes in the chemical shifts for a number 
of protons on 24+ were observed on addition of GMP, these were 
difficult to quantify as they were accompanied by significant 
signal broadening. However, significant chemical shifts were 
simultaneously observed for several GMP signals. Notably, the 
purine proton at the 8-position shifted from 7.95 to 8.06, and the 
1’ sugar proton 5.60 to 5.75. Fitting these latter changes to a 
simple 1:1 guest-host binding model gave a Ka of 8.3 x 102 M-1. It 
is known that large anions can interact with dinuclear complexes 
by binding into the cleft defined by ancillary and bridging 
ligands. Indeed, this has formed the basis of chromatographic 
separation of stereoisomers of such complexes.54-56 Thus, the 
observed NMR shifts indicate that GMP interacts with 24+ in this 
manner.
The emission quenching data were then fitted using the 
relationship: 57
𝐼0
𝐼 = (1 + 𝑘𝑞𝜏0[𝑄])(1 + 𝐾𝑎[𝑄]).
Where, kq is the quenching constant, 0 is the emission lifetime 
of 24+ without a quencher, [Q] is quencher concentration and Ka 
the association constant. This analysis gives a quenching constant 
of 1.2 x 108  M-1 s-1. No significant emission quenching was 
observed on addition of A, T and C monophosphates confirming 
that - as expected from previous studies - quenching was 
exclusive to GMP
For the interaction of 24+ with both duplex and quadruplex 
DNA was the investigated through absorption and luminescence 
titrations. To aid comparisons, all titrations in these studies (and 
the SI) were carried out in high ionic strength phosphate buffer, 
which is consistent with quadruplex folding (10mM KH2PO4, 
200mM KCl, 0.1M EDTA, pH 7.0). Absorption measurements 
were taken in parallel, both to assess any changes in the 
absorption spectrum itself and to correct the emission intensities.
As expected from the GMP experiments and similar studies on 
[Ru(TAP)2(dppz)]2+, complex 24+ shows emission quenching on 
binding to CT-DNA – Figure 7A. 34,36 Again, this observation is 
consistent with a RuIITAP-based 3MLCT excited state and 
indicates the expected photoredox quenching by G-sites within 
the duplex. This is confirmed by the fact that addition of Poly(A)-
Poly(T) causes a slight increase in emission (see SI).
DNA-induced changes were also observed in the absorption 
spectrum of 24+ – Figure 7B. The MLCT transition at 420 nm 
shows a significant decrease in intensity throughout the titration. 
Approaching the end point of the titration, a new shoulder at 460 
nm appears to grow in, suggesting that binding to CT-DNA may 
affect the energy of excited states. This is consistent with the 
previously described DFT calculations indicating that order of the 
close lying excited states of the complex is sensitive to its 
environment.
Attempts to fit the titration data to the well-known McGhee-
von Hippel model58 were unsuccessful; it is possible that this is 
due to the presence of multiple binding modes. However, the 
absorbance data fitted well to the simpler binding model 
described by Srishailam, et al,7  Figure 7C, resulting in an 
estimated Kb of 2 x 106 M-1, which is of the same order of 
magnitude as isostructural 14+,19 implying the addition of the 
heteroaromatic nitrogens to the ligands does not significantly 
affect binding to duplex DNA.
Previous work within the Thomas group has shown that 14+ 
binds to quadruplex-folded human telomere sequence (HTS) with 
high affinity.19,20,23 Therefore, analogous experiments were 
carried out with 24+ using the same experimental conditions. 
HTS-induced changes in emission spectra are similar to those 
observed on CT-DNA addition; as HTS is G-rich quenching by 
G-sites is again expected– Figure 7D. However, a closer 
inspection reveals differences in the absorption changes induced 
by binding to HTS and CT-DNA – Figure 7E. In particular, 
whilst an initial decrease in absorption of the 423 nm band is 
observed on addition of HTS, the subsequent grow-in of the band 
at 460 nm observed in duplex binding does not occur, suggesting 
that binding to quadruplex does not affect the energy of excited 
states of 24+ in the same way as duplex binding.
The emission titration data was also best fitted to a one-set-of-
sites binding + non-specific interaction model, – Figure 7F. This 
yielded an estimated binding constant of 5.1 x 105 M-1, which is 
an order of magnitude lower than the binding constant to the 
duplex and twenty-fold lower than the binding of 14+ to HTS.
The difference in quadruplex binding affinities between the 
two complexes may be explained by a consideration of our 
previously reported NMR–based HTS/14+ structure, which shows 
close contacts between the ancillary ligands of 14+ and the 
diagonal loops of the quadruplex structure. It seems the lone pairs 
of the aromatic nitrogen of the ancillary TAP ligands destabilizes 
this interaction through unfavourable interactions with similar 
basic sites within the diagonal loop. 
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Fig. 7 CT-DNA and HTS titration data for [2]Cl4 (5 M concentration, in phosphate buffer A) Changes in emission spectra upon addition of CT-DNA. B) 
Changes in absorption spectra with CT-DNA. C) Binding curve for the data obtained with CT-DNA based on absorption data– red line shows fit to model 
developed by Srishailam, et al.7 D) Changes in emission spectra upon addition of HTS. E) Changes in absorption spectra of [2]Cl4 upon addition of HTS. 
F) Binding curve for [2]Cl4 with HTS based on emission data– red curve shows fitting to a one-set-of-sites binding + non-specific interaction mode.
To further investigate the changes in the excited state of DNA 
bound 24+ transient absorption experiments were carried out. 
Absorption transients were measured in phosphate buffer at a 
concentration of 0.1mM complex – Figs 8 and 9. Global lifetime 
analysis of the TA data was carried out using Glotaran 1.5.1, 59 
with kinetics of selected processes fitted using Origin 8.0.
Previous studies on Ru complexes of dppz and tpphz have 
revealed that intense transient bands in the 500-800 nm region are 
produced by charge transfer to the phenazine moiety of the 
ligands.36,60-63 However, the computational and steady-state 
optical studies described above suggested that the lowest excited 
state for complex 24+ is a RuTAP MCLT. These conclusions 
are further supported by the transient spectra for [2]Cl4 which 
show that the strong ground-state bleach of the MLCT absorption 
bands between 400-500 nm is accompanied by the growth of a 
weak transient between 500-650nm, changes which occur 
immediately following the pump pulse (within 1 ps) – Fig 8A. 
These observations are consistent with previous studies on  
[Ru(TAP)2(dppz)]2+ in solution - which also shows a weak, 
broad, largely featureless transient absorption between 500-650 
nm – and confirm that 24+ displays a TAP centred excited 
state34,64
There are no significant changes in spectral shape throughout 
the time-window of the experiment (7900 ps). Global fitting of 
the spectra using 4-exponential decay parameters gave the most 
reliable fitting of the data. The two fastest components of under 
~1 ps, are followed by simultaneous decay of the entire spectrum, 
with components of 355 ps and ~100 ns. The slow component is 
assigned to the emissive excited state observed above. The 355 ps 
component is likely to be due to conversion of a multitude of 
initially-formed excited states to the long-lived RuTAP 3MLCT 
state, as lifetimes of a similar order of magnitude have been 
previously observed for [Ru(TAP)2(dppz)]2+ and related 
complexes.
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Fig. 8 Selected transient absorption data for [2]Cl4 following  ~40 fs, 400 nm excitation. A) In phosphate buffer. B) In phosphate buffer with 1 mM CT-
DNA. C) In phosphate buffer with 1 mM HTS.
Significantly, in both the CT-DNA and HTS experiments, 
but not a distinctive signal at approximately 515 nm emerges – 
Fig 9. A very similar transient is observed when DNA is added 
to  [Ru(TAP)2(dppz)]2+ and this was assigned to the generation 
of the guanine radical cation as a photo-oxidization 
product.35,36,64,65 Interestingly, this feature is appreciably more 
prominent on addition of HTS, which as a sequence possesses a 
higher density of G-residues compared to CT-DNA, and is 
therefore more likely to undergo photo-oxidation on exposure 
to light.
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Fig. 9 Selected transient absorption spectra for [2]Cl4 in phosphate 
buffer with and without CT-DNA and HTS, showing the growth of the 
transient band at ~515 nm.
The excited state dynamics of 24+ in the presence of CT-
DNA and HTS are complex, with global lifetime analysis 
suggesting a minimum of four distinct excited state processes. 
The lifetimes of these states are of similar magnitude in the 
presence of both CT-DNA and HTS (Table 2).
Table 2. Lifetimes obtained from global lifetime analysis of 
transient absorption data
Lifetimes (ps)
CT-DNA HTS
 3.6 ± 0.4 2.9 ± 0.2
 275 ± 12 330 ± 17
 2900 ± 150 2930 ± 130
 >30,000 > 30,000
The decay-associated spectra (see SI) for each excited state 
process feature a grow-in signal at ~510 nm, associated with 
the photooxidation of guanine. This implies that this photo-
oxidation process can occur in parallel from multiple excited 
states. Unfortunately, there is insufficient detail in the transient 
absorption data to accurately model these processes. However, 
by isolating and fitting the feature at 510 nm using a 3-
exponential model, the major lifetime component of this 
growth is 1808 ± 100 ps for CT-DNA and 1592 ± 90 ps for 
HTS.  The faster kinetics for HTS is consistent with the 
anticipated intimate contact between 24+ and guanine tetrads of 
the four-stranded structure.
The intricacies of the dynamics reflect the complexity of 
binding modes and the numerous potential photochemical 
pathways following photoexcitation. Assuming the lowest 
triplet excited state of the complex is a RuTAP  3MLCT state 
(as confirmed by the calculations), then subsequent 
simultaneous photooxidation of guanine, radiative and non-
radiative decay, as well as c of the oxidised guanine residues 
will all contribute to the spectral evolution. Significantly more 
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detailed analyses, such as time-resolved infrared spectroscopy, 
will be required to fully dissect the subtleties, which will form 
the basis of a future report. Nevertheless - although it is clear 
that 24+ preferentially binds to duplex over quadruplex DNA - 
the cell-free studies described above confirm that this complex 
does participate in photo-induced redox reactions with G-sites, 
whether they are found in duplex or quadruplex structures.
With these promising results in mind, the live cell uptake 
and localization of 24+ was investigated. For reasons of 
therapeutic need, malignant human melanoma cells were 
specifically chosen for these studies.
Melanoma is one of the most aggressive and therapeutically 
resistant cancers. If diagnosed and treated in its early stages it 
has an 80% 10-year remission rate. However, if it spreads to 
the lymph nodes this figure drops to only 10%.66 In 2017 
malignant melanoma was responsible for 72% of skin cancer 
deaths in the USA and its incidence continues to rise.67 One of 
the difficulties in treating melanoma is that it displays a range 
of therapeutic resistance mechanisms,68 so alternative treatment 
regimes are being actively sought.69 In this context, it has been 
suggested that PDT could provide a novel therapeutic modality 
for this cancer.66,70 We chose to investigate the effect of 24+ on 
human C8161 melanoma cells as this line is known to be 
highly invasive and spontaneously metastatic71, and thus it 
represents a relevant and therapeutically challenging treatment 
target.
Fig. 10 Intracellular localization and uptake of [2]Cl4 in human C8161 
melanoma cells – labelled Ru-Ru TAP in diagrams. Co-staining with 
cytoplasm stains LysoTracker Green (Top) and MitoTracker Green 
(bottom) show low colocalisation with [2]Cl4. (Pearson coefficient = 
0.06±0.01, and 0.12±0.04, respectively, SB 10µm). Co-staining with 
nuclear stain DAPI (centre) reveals a significantly higher co-
localisation (Pearson coefficient = 0.51±0.19, scale bar = 10µm).
Encouragingly, it was found that the complex was 
spontaneously taken up by live C8161 cells,  and it produced 
bright intracellular emission.  Furthermore, co-staining using 
24+ (100 µM, 24hours) and the standard nuclear stain DAPI, 
reveals DAPI co-localizes with the new complex, displaying a 
Pearson coefficient of 0.51. These observations confirm that - 
like its close analogue 14+ - complex 24+ is cell and nuclear 
membrane permeant. However, unlike 14+, treatment with 24+ 
also leads to bright emission from the cytoplasm of the 
melanoma cells, therefore analogous co-staining experiments 
with commercial stains were carried out, Figure 10.
Fig. 11 Phototoxicity of 24+ on melanoma. human melanoma cells 
(C8161) were treated at a series concentration of 24+ (0, 10, 50, 100, 
200 µM). Photo-toxicity was assessed using a 405 ± 20nm wavelength 
light from a ThorLab LED lamp (M405LP1, power output 1500mA) on 
exposure to fluences of 6 J cm-2, 12 J cm-2 and 18 J cm-2, respectively. 
No cell death was observed with an increase in 24+ compound 
concentration.  However, cell viability decreased significantly after 
exposure to 405 ± 20nm light with pre-treated melanoma cells (e.g. 100 
µM with 1 hour (▪) light activation causes > 50% reduction in cell 
viability). LD50 value calculated (for each line interpolate sigmoidal) 
using Prism software. The error bars denotes SEM (n=3).
These studies revealed some correlation between the 
emission of the complex and that of the MitoTracker Green and 
LysoTracker Green labels. However, calculated Pearson 
coefficients of 0.12 and 0.06, respectively, indicate localization 
of 24+ within these organelles is significantly lower than within 
nuclei. This is consistent with recent super-resolution and TEM 
studies72 that revealed that, while 14+ is only brightly emissive 
from the nucleus, it does exhibit significant mitochondrial 
localization.  The difference in the intracellular luminescence 
of the complexes can be attributed to the fact that whilst 14+ 
displays off/on DNA light-switch emission, 24+ is emissive, 
unless quenched by photo-redox processes.
To facilitate a more detailed understanding of cellular 
uptake, the concentration- and time-dependent uptake of 24+ 
was explored – See SI. It was found that intracellular emission 
intensity correlates with increased concentrations and exposure 
times. These studies confirmed that the complex readily 
diffuses into cells, where initially it predominately labels the 
nucleus, but then diffuses more generally throughout the cell.
Having established uptake by live melanoma cells and 
specific sub-cellular localizations, the cytotoxicity and 
phototoxicity of 24+ was then investigated. Cell viabilities after 
exposure to different concentrations of the complex in the dark 
after 24 hours were quantified using the AlamarBlue method - 
Figure 11.58-60 
These studies indicated that the initial seeding density of 
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1x105 cells/well does not change on treatment with the 
complex. Indeed, at all concentrations, no statistical difference 
in cell viability was observed compared to cells of non-treated 
controls, suggesting the complex displays negligible 
cytotoxicity in dark conditions (see SI). Experiments were then 
carried out in which melanoma cells treated with various 
concentrations of complex were irradiated into the MLCT band 
using a 405 ± 20 nm LED laser. Light treated cells were then 
incubated for 3 hours, and a change in cell viability measured, 
and plotted against various concentrations of 24+.
Irradiation at low fluences, with a maximum of only 18 J 
cm-2, showed a dose-response hyperbolic curve, revealing a 
radical drop to effectively zero cell-viability at exposure to  
100uM of 24+, compared to non-irradiated cells. A similar 
pattern of concentration-dependent cell death was also seen on 
exposure to a broad-spectrum blue light, a regime commonly 
employed by dermatologists in the treatment of topical skin 
conditions such as acne.73 We note that this treatment required 
longer time exposures, but this is probably due to differences in 
power output. Nonetheless, the new complex is therapeutically 
active at fluences that are around an order of magnitude lower 
than those commonly employed for commercial sensitizers in 
the treatment of cancer, including basal cell skin cancer. 74-77
Conclusions
Complex 24+ displays similar photophysical properties to 
previously reported systems based on the (TAP)2RuII moiety in 
that it displays a reactive RuTAP MLCT excited state that 
photo-oxidizes guanosine moieties. Steady-state and time-
resolved studies indicate that the complex participates in 
similar process when bound to both duplex and G-rich, 
quadruplex DNA. Crucially, this new compound is 
spontaneously taken up by live melanoma cells, largely 
localizing in nuclei. The complex shows no toxicity under dark 
condition, even at high concentrations (e.g. 200 M). However, 
once sensitized with light, it becomes highly toxic to human 
melanoma cells, making it an efficient and promising lead as a 
photosensitizer for PDT.1
Complex 24+ binds to a quadruplex structure with affinities 
that are around an order of a magnitude weaker than those 
displayed for duplex binding. Given that conventional duplex 
DNA vastly outnumber putative quadruplex sequences within 
the genome,78-81 it seems likely that the photo-cytotoxic effects 
of this complex is largely due to damage to duplex sequences.  
However, damage to quadruplex structures could still be 
disproportionately large. Previous studies using photo-redox 
active metal complexes have demonstrated that G-rich 
sequences, particularly runs of neighbouring G-sites, are 
susceptible to redox damage, 51,82 even when distal to the metal 
complex binding site 83-86. Furthermore, experimental evidence 
has accrued that quadruplexes can behave as oxidative traps for 
long-range charge-transfer. 87,88 For this reason it has been 
suggested that telomeres may be oxidation hot-spots or traps 
for oxidative damage to genomic content. 88,89 Inter alia, future 
studies involving 24+ will assess the likelihood of this 
hypothesis. Inspired by this lead, the synthesis of related photo-
redox active structures that display higher selectively for 
quadruplex over duplex DNA would provide a novel form of 
telomere targeted PDT; work on targeting such structures is 
currently underway.
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